Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Prim. 2020;6:93.
Google ScholarÂ
Olajide M, Ladeji A, Adebiyi K, Abah A. Clinicopathologic profile of oral squamous cell carcinoma (OSCC) and sinonasal squamous cell carcinoma (SNSCC). Oral Surg, Oral Med, Oral Pathol Oral Radiol. 2021;132:e32.
Google ScholarÂ
Joshi P, Bane S, Chaturvedi P, Gera P, Waghmare SK. Establishment and characterization of patient-derived tongue squamous cell carcinoma cell lines. Hum Cell. 2025;38:102.
Google ScholarÂ
Li C, Peng W, Zhong Z, Zhang C, Wang X, Qin R, et al. CRISPR/Cas9 library screening reveals that STK19 has synergistic antitumor effects when combined with cisplatin on tongue squamous cell carcinoma. J Transl Med. 2025;23:1142.
Google ScholarÂ
Ghazi N, Saghravanian N, Anvari K, Saghafi Khadem S, Hoseinzadeh M, Barzanouni R. Evaluation of survival rate in patients with tongue squamous cell carcinoma: a retrospective single-center study. BMC Oral Health. 2025;25:658.
Google ScholarÂ
Gao Z, Zhu X, Dou Y. The miR-302/367 cluster: a comprehensive update on its evolution and functions. Open Biol. 2015;5:150138.
Google ScholarÂ
Barroso-delJesus A, Romero-López C, Lucena-Aguilar G, Melen GJ, Sanchez L, Ligero G, et al. Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol. 2008;28:6609–19.
Google ScholarÂ
Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic acids Res. 2019;47:D155–D62.
Google ScholarÂ
Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, Lee JY, et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol. 2004;270:488–98.
Google ScholarÂ
Sugawara T, Kawamoto Y, Kawasaki T, Umezawa A, Akutsu H. A single allele of the hsa-miR-302/367 cluster maintains human pluripotent stem cells. Regen Ther. 2022;21:37–45.
Google ScholarÂ
Yang T, Tian S, Wang L, Wang Y, Zhao J. MicroRNA-367-3p overexpression represses the proliferation and invasion of cervical cancer cells through downregulation of SPAG5-mediated Wnt/β-catenin signalling. Clin Exp Pharm Physiol. 2020;47:687–95.
Google ScholarÂ
Hwang YS, Park ES, Oh BM, Uhm TG, Yoon SR. miR-302 Suppresses the Proliferation, Migration, and Invasion of Breast Cancer Cells by Downregulating ATAD2. Cancers. 2022;14:4345.
Google ScholarÂ
Wang Y, Zhao L, Xiao Q, Jiang L, He M, Bai X, et al. miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells. Gynecol Oncol. 2016;141:592–601.
Google ScholarÂ
Alemi M, Taha MF, Bazargani A, Babaali V, Nemati H, Javeri A. Suppression of mTOR signaling by miR-302/367 cluster in breast cancer cells. FASEB J. 2025;39:e70943.
Google ScholarÂ
Wang L, Yao J, Zhang X, Guo B, Le X, Cubberly M, et al. miRNA-302b suppresses human hepatocellular carcinoma by targeting AKT2. Mol cancer Res: Mcr. 2014;12:190–202.
Google ScholarÂ
Cao YP, Pan M, Song YL, Zhang HL, Sui HT, Shan BC, et al. MiR-302 a/b/c suppresses tumor angiogenesis in hepatocellular carcinoma by targeting MACC1. Eur Rev Med Pharmacol Sci. 2019;23:7863–73.
Google ScholarÂ
Guo B, Zhao Z, Wang Z, Li Q, Wang X, Wang W, et al. MicroRNA-302b-3p suppresses cell proliferation through AKT pathway by targeting IGF-1R in human gastric cancer. Cell Physiol Biochem. 2017;42:1701–11.
Google ScholarÂ
Ma G, Li Q, Dai W, Yang X, Sang A. Prognostic implications of miR-302a/b/c/d in human gastric cancer. Pathol Oncol Res: Por. 2017;23:899–905.
Google ScholarÂ
Cao J, Li L, Han X, Cheng H, Chen W, Qi K, et al. miR-302 cluster inhibits angiogenesis and growth of K562 leukemia cells by targeting VEGFA. OncoTargets Ther. 2019;12:433–41.
Google ScholarÂ
Bailey S, Ferraresso M, Alonso-Crisostomo L, Ward D, Smith S. Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption. Br J Cancer. 2023;129:1451–61.
Google ScholarÂ
Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006;124:1169–81.
Google ScholarÂ
Jiang WJ, Zhou TH. Breast cancer subtype-specific organotropism is dictated by FOXF2-regulated metastatic dormancy and recovery. Cancer Res. 2025;85:644–59.
Google ScholarÂ
Aggrey-Fynn JE, Manjunath M, Rajput A, Abdelrahman AM. Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis. Cell Death Dis. 2025;16:504.
Google ScholarÂ
Chen S, Zhang D, Du Y, Shi J, Gu S, Zhou X, et al. Targeting TRAF6/IRF3 axis to inhibit NF-κB-p65 nuclear translocation enhances the chemosensitivity of 5-FU and reverses the proliferation of gastric cancer. Cell Death Dis. 2024;15:924.
Google ScholarÂ
Lu Q, Lv X, Wang J, Xia B, Yan H, Wang Z, et al. Methylation-mediated LncRNA CRAT40 promotes colorectal cancer progression by recruiting YBX1 to initiate RelA transcription. Int J Biol Sci. 2025;21:4834–50.
Google ScholarÂ
Köhler UA, Böhm F, Rolfs F, Egger M, Hornemann T, Pasparakis M, et al. NF-κB/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to prevent development of hepatocellular adenoma. J Hepatol. 2016;64:94–102.
Google ScholarÂ
Wu Z, Wang Z, Zheng D, Zheng Y, Jiang Z, Lv J, et al. RELA ablation contributes to progression of hepatocellular carcinoma with TP53(R249S) mutation and is a potential therapeutic target. Adv Sci (Weinh). 2025;12:e00335.
Google ScholarÂ
Liu F, Zhang X, Peng Y, Zhang L, Yu Y, Hua P, et al. miR-24 controls the regenerative competence of hair follicle progenitors by targeting Plk3. Cell Rep. 2021;35:109225.
Google ScholarÂ
Beronja S, Livshits G, Williams S, Fuchs E. Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos. Nat Med. 2010;16:821–7.
Google ScholarÂ
Hou A, Zhang Y, Zheng Y, Fan Y, Liu H, Zhou X. LncRNA terminal differentiation-induced ncRNA (TINCR) sponges miR-302 to upregulate cyclin D1 in cervical squamous cell carcinoma (CSCC). Hum Cell. 2019;32:515–21.
Google ScholarÂ
Tabrizi M, Khalili M, Vasei M, Nouraei N, Mansour Samaei N, Khavanin A, et al. Evaluating the miR-302b and miR-145 expression in formalin-fixed paraffin-embedded samples of esophageal squamous cell carcinoma. Arch Iran Med. 2015;18:173–8.
Google ScholarÂ
Bourguignon LY, Wong G, Earle C, Chen L. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem. 2012;287:32800–24.
Google ScholarÂ
Xue N, Wang Y, Wang Z, Zeng X, Wang J, Zhang X. Trends in immunotherapy for oral squamous cell carcinoma. Cell Oncol. 2025;48:1159–79.
Google ScholarÂ
Sheng N, Fu R, Zhou C, Li Y, Fan Y, Wang J, et al. SOX9 promotes stemness in the CAL27 cell line of tongue squamous cell carcinoma. Cell Biochem Funct. 2024;42:e4000.
Google ScholarÂ
Sun Y, Chen Y, Zhao H, Wang J, Liu Y, Bai J, et al. Lactate-driven type I collagen deposition facilitates cancer stem cell-like phenotype of head and neck squamous cell carcinoma. iScience. 2024;27:109340.
Google ScholarÂ
Chiu H-W, Lin C-H, Lee H-H, Lu H-W, Lin Y-HK, Lin Y-F, et al. Guanylate binding protein 5 triggers NF-κB activation to foster radioresistance, metastatic progression and PD-L1 expression in oral squamous cell carcinoma. Clin Immunol. 2024;259:109892.
Google ScholarÂ
Kaur S, Sharma N, Krishn SR, Lakshmanan I, Rachagani S, Baine MJ, et al. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. Clin Cancer Res. 2014;20:688–700.
Google ScholarÂ
Mahadevan NR, Rodvold J, Almanza G, Pérez AF, Wheeler MC, Zanetti M. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner. BMC cancer. 2011;11:229.
Google ScholarÂ
Hai L, Zhang C, Li T, Zhou X, Liu B, Li S, et al. Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway. Cell Death Dis. 2018;9:158.
Google ScholarÂ

